Literature DB >> 29607167

Protective effects of PI3KCG gene on acute myocardial infarction.

Ge Gong1,2, Xin-Xing Yang1, Yan-Yan Li1, Hong-Yu Geng1, Hui Wang3, Lian-Sheng Wang3, Zhi-Jian Yang3.   

Abstract

BACKGROUND: To study the protective effects of recombinant phosphatidylinositol 3-kinase p110 gamma (rPLV-PI3KCG) lentiviral vector in Sprague-Dawley (SD) rats with acute myocardial infarction (AMI).
METHOD: The AMI rat models were established by ligaturing left anterior descending coronary artery. The rPLV-PI3KCG or empty lentiviral vectors were injected at the edge of the infarct zone. The experiment was divided randomly into four groups (n=8): (I) Sham group; (II) AMI group; (III) AMI + empty vector injection group (AMI + E group); and (IV) AMI + PLV-PI3KCG injection group (AMI + PLV-PI3KCG group). The ultrasonic cardiogram (UCG) was used to compare the structural or functional changes among the four groups after operation for 10 days. Meanwhile, the rats were sacrificed and HE staining was used to compare the myocardial tissue changes among the four groups. The immunofluorescence and western blots were performed to compare the angiogenesis in the infarct region and explore the mechanism of the protective effects of PI3KCG gene on AMI rats.
RESULTS: Compared with AMI group and AMI + E group, in the AMI + PLV-PI3KCG group, left ventricular end diastolic diameter (LVEDd) was decreased, left ventricular ejection fraction (LVEF%) was significantly increased, and vascular endothelial growth factor (VEGF) expression was significantly increased in the infarct region (P<0.05); PI3KCG, pAkt/Akt, HIF-1a, and Bcl-2/Bax protein expressions were significantly increased (P<0.05).
CONCLUSIONS: The rPLV-PI3KCG injection could improve the cardiac function, relieve the cardiac injury after the AMI operation. PI3KCG gene could play the protection role in the AMI process possibly by activating PI3K/Akt signal pathway, inhibiting apoptosis and promoting angiogenesis.

Entities:  

Keywords:  PI3KCG; acute myocardial infarction (AMI); apoptosis; lentiviral vector

Year:  2018        PMID: 29607167      PMCID: PMC5864685          DOI: 10.21037/jtd.2018.01.59

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  31 in total

Review 1.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

Review 2.  The emerging mechanisms of isoform-specific PI3K signalling.

Authors:  Bart Vanhaesebroeck; Julie Guillermet-Guibert; Mariona Graupera; Benoit Bilanges
Journal:  Nat Rev Mol Cell Biol       Date:  2010-04-09       Impact factor: 94.444

3.  The cardioprotective effect of dihydromyricetin prevents ischemia-reperfusion-induced apoptosis in vivo and in vitro via the PI3K/Akt and HIF-1α signaling pathways.

Authors:  Shasha Liu; Qidi Ai; Kai Feng; Yubing Li; Xiang Liu
Journal:  Apoptosis       Date:  2016-12       Impact factor: 4.677

4.  A soluble receptor for advanced glycation end-products inhibits myocardial apoptosis induced by ischemia/reperfusion via the JAK2/STAT3 pathway.

Authors:  Xue Jiang; Cai-xia Guo; Xiang-jun Zeng; Hui-hua Li; Bu-xing Chen; Feng-he Du
Journal:  Apoptosis       Date:  2015-08       Impact factor: 4.677

5.  PI3K(p110 alpha) protects against myocardial infarction-induced heart failure: identification of PI3K-regulated miRNA and mRNA.

Authors:  Ruby C Y Lin; Kate L Weeks; Xiao-Ming Gao; Rohan B H Williams; Bianca C Bernardo; Helen Kiriazis; Vance B Matthews; Elizabeth A Woodcock; Russell D Bouwman; Janelle P Mollica; Helen J Speirs; Ian W Dawes; Roger J Daly; Tetsuo Shioi; Seigo Izumo; Mark A Febbraio; Xiao-Jun Du; Julie R McMullen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-04       Impact factor: 8.311

6.  MAPK and Akt act cooperatively but independently on hypoxia inducible factor-1alpha in rasV12 upregulation of VEGF.

Authors:  A Sodhi; S Montaner; H Miyazaki; J S Gutkind
Journal:  Biochem Biophys Res Commun       Date:  2001-09-14       Impact factor: 3.575

7.  Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration.

Authors:  A V Bakin; A K Tomlinson; N A Bhowmick; H L Moses; C L Arteaga
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

8.  TWEAK protects cardiomyocyte against apoptosis in a PI3K/AKT pathway dependent manner.

Authors:  Bin Yang; Ping Yan; Hui Gong; Lin Zuo; Ying Shi; Jian Guo; Rui Guo; Jun Xie; Bao Li
Journal:  Am J Transl Res       Date:  2016-09-15       Impact factor: 4.060

9.  Simvastatin activates Akt/glycogen synthase kinase-3beta signal and inhibits caspase-3 activation after experimental subarachnoid hemorrhage.

Authors:  Gao Cheng; Wang Chunlei; Wu Pei; Liu Zhen; Liu Xiangzhen
Journal:  Vascul Pharmacol       Date:  2009-12-18       Impact factor: 5.773

10.  Activation of Akt/GSK-3beta signaling pathway is involved in intermedin(1-53) protection against myocardial apoptosis induced by ischemia/reperfusion.

Authors:  Jun-Qiu Song; Xu Teng; Yan Cai; Chao-Shu Tang; Yong-Fen Qi
Journal:  Apoptosis       Date:  2009-11       Impact factor: 4.677

View more
  3 in total

1.  The regulatory effect of microRNA-21a-3p on the promotion of telocyte angiogenesis mediated by PI3K (p110α)/AKT/mTOR in LPS induced mice ARDS.

Authors:  Yile Zhou; Yajie Yang; Tao Liang; Yan Hu; Haihong Tang; Dongli Song; Hao Fang
Journal:  J Transl Med       Date:  2019-12-26       Impact factor: 5.531

2.  Effect of the WeChat Platform Health Management and Refined Continuous Nursing Model on Life Quality of Patients with Acute Myocardial Infarction after PCI.

Authors:  Meifang Xu; Xiaofang Yang; Lin Liu; Yunlang Dai; Mingzhu Xu; Shi Lin
Journal:  J Healthc Eng       Date:  2021-11-29       Impact factor: 2.682

3.  Comparative Transcriptome Analyses of Geriatric Rats Associate Age-Related Erectile Dysfunction With a lncRNA-miRNA-mRNA Regulatory Network.

Authors:  Xuan Zhou; Rong Cong; Liangyu Yao; Xiang Zhou; Jiaochen Luan; Qijie Zhang; Xu Zhang; Xiaohan Ren; Tongtong Zhang; Xianghu Meng; Ninghong Song
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-11       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.